Results 151 to 160 of about 57,833 (235)

Reversing chemoresistance in ovarian cancer: network pharmacology reveals how hydroxychloroquine/sulfasalazine duotherapy remodels tumor inflammatory-immune microenvironment. [PDF]

Front Immunol
Hong X, Wen X, Zhang T, Liu Y, Ji Y, Shen X.   +5 more
europepmc   +1 more source

Unusual Palatal Pigmentation in a 71‐Year‐Old Patient

Oral Diseases, EarlyView.
Lucía Lago‐Méndez, Carlos Manuel de Neira de Paz, Pedro Diz‐Dios, Márcio Diniz‐Freitas   +3 more
wiley   +1 more source

Refractory Relapsing–Remitting Adult‐Onset Still's Disease in an Adolescent Female: A Rare Case Report

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Adult‐onset Still's disease (AOSD) is a rare systemic autoinflammatory condition that presents with symptoms such as episodic fevers, a transient rash, inflammatory arthritis, and significant systemic inflammation. Diseases that have a relapsing–remitting clinical course can be challenging to diagnose and treat. We present a case of an 18 year
Tasnim Nafian, Mohd. Mujtaba Akib Bhuiyan, Kazi Ali Aftab, Khaled Mahbub Murshed, Md. Abul Kalam Azad   +4 more
wiley   +1 more source

Home care for patients with COVID-19: Niger's experience; about 2037 cases in the city of Niamey. [PDF]

IJID Reg
Moussa Saley S, Saidou Chaibou N, Mamadou Boulama BM, Ali Z, Ganda OR, Yahayé H, Akoïna Abomtcho E, Mamadou Amadou G, Alkassoum Salifou I, Adehossi E.   +9 more
europepmc   +1 more source

Multifaceted Roles of Chloroquines in Gastrointestinal Disorders and Beyond

Comprehensive Physiology, Volume 16, Issue 4, August 2026.
Chloroquine (CQ) and hydroxychloroquine (HCQ) modulate lysosomal activity and autophagy, suppressing gastrointestinal inflammation and reshaping pathogenic microbiota. These mechanisms alleviate inflammatory bowel disease, inhibit associated tumor growth, and provide benefits in certain autoimmune and viral conditions.
Sihyun Jeong, Eunsoo Kim, Yong Sung Kim, Eunok Im   +3 more
wiley   +1 more source

Tripterygium Glycoside Tablets Combined With Conventional Synthetic Disease-Modifying Antirheumatic Drugs for Treating Rheumatoid Arthritis: Protocol for a Prospective, Multicenter, Open-Label Randomized Controlled Trial. [PDF]

JMIR Res Protoc
Lv L, Wang T, Lv J, Liu C, Zhao L, Zhou Y.   +5 more
europepmc   +1 more source

Clinicopathological Features of Lupus Erythematosus Panniculitis (LEP): A Retrospective Analysis of 54 Cases

Health Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background Lupus Erythematosus Panniculitis (LEP) is a rare subtype of Cutaneous Lupus Erythematosus. It is a challenging disease to diagnose and treat due to limited understanding of its clinical and histopathological characteristics. Methods We conducted a retrospective review of 54 biopsy‐proven LEP cases evaluated at a dermatology referral
Maryam Nasimi, Narjes Ramezani, Kambiz Kamyab, Alireza Abdshah, Maryam Ghiasi, Sahar Montazeri, Hanie Babaie, Fatemeh Saberi   +7 more
wiley   +1 more source

Correction: Aljubailah et al. Copolymer Involving 2-Hydroxyethyl Methacrylate and 2-Chloroquinyl Methacrylate: Synthesis, Characterization and In Vitro 2-Hydroxychloroquine Delivery Application. <i>Polymers</i> 2021, <i>13</i>, 4072. [PDF]

Polymers (Basel)
Aljubailah A, Alharbi WNO, Haidyrah AS, Al-Garni TS, Saeed WS, Semlali A, Alqahtani SMS, Al-Owais AA, Karami AM, Aouak T.   +9 more
europepmc   +1 more source

Autophagy Modulation in Cancer Therapy: Navigating the Dual Roles to Overcome Chemoresistance

Health Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background Autophagy is a fundamental cellular recycling mechanism with complex and often opposing roles in cancer, functioning as both a tumor suppressor and a pro‐survival mechanism in established tumors. This duality has attracted considerable attention, particularly regarding the therapeutic modulation of autophagy to overcome ...
Md Mohiuddin, Md Al Mamun Ahsan
wiley   +1 more source

Acute generalized exanthematous pustulosis sine pustules: A case report. [PDF]

JAAD Case Rep
Ali A, O'Brien MA, Hsu S.
europepmc   +1 more source